Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 21, 2024Experimental and Clinical Endocrinology & Diabetes

Dihydromyricetin improves high glucose induced dopaminergic neuronal damage by activating AMPK-autophagy signaling pathway

View Full Paper
Ask AI
Bookmark
Share

Authors

QLQi LiZSZhenjiang SongLPLiting Peng

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e5b746b6db64358754fc9fhttps://doi.org/10.1055/a-2399-1174
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway2024 · 68 citations
  2. 2Dihydromyricetin regulates RIPK3-CaMKII to prevent necroptosis in high glucose-stimulated cardiomyocytes2024 · 10 citations
  3. 3Dihydromyricetin mitigates T2DM progression by modulating bile acid metabolism through SHP/PPARγ pathway2026
  4. 4Dihydromyricetin preserves β-cell function in type 1 diabetes via PI3K/AKT-mediated metabolic reprogramming2025 · 2 citations
  5. 5Dihydromyricetin promotes GLP-1 secretion to improve insulin resistance via “gut microbiota-CDCA”2024